mp-healthcare.com
MP Healthcare Venture Management : Portfolio
http://www.mp-healthcare.com/portfolio.html
Our investment portfolio includes companies passionate about the development and commercialization of innovative products and platform technologies for the prevention, diagnosis and treatment of significant diseases. Thrasos Therapeutics is a clinical-stage biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The company is advancing therapeutic programs, led by THR-184, for renal diseases, including acute kidney in...
imvacs.com
Immunomodulatory Therapeutic Antibodies for Cancer Conference
http://www.imvacs.com/Immunomodulatory-Antibodies-Cancer
Cambridge Healthtech Institute’s 3rd Annual. Immunomodulatory Therapeutic Antibodies for Cancer. The Evolution of the PD-1 Axis, Emerging Immunotherapy Targets and Indications, Developing Multifunctional Antibody Immunotherapies. Will explore developments in mainstream and emerging targets in this space, review progress in the application of immunotherapy for difficult to treat cancers and consider different concepts for developing multifunctional antibody immunotherapies. Day 1 Day 2. MONDAY, AUGUST 24.
biohive.net
September 2013 | BioHive
http://www.biohive.net/2013_09_01_archive.html
Monday, 2 September 2013. Monday, September 02, 2013. Maintaining a healthy pipeline and a steady revenue stream are on the top of the priority list for pharma and biotech companies. 2013 has been a interesting year so far, with most companies finishing off making their moves in order to defend against the patent cliff, cut costs, or even "redefine" themselves ( Pfizer had begun the cost-cutting exercise in 2010-2011. AstraZeneca continues to buy. So, let's begin.The graph and table below contain the...
fassino.wordpress.com
Fassino Design News and Blog | News and ideas from Fassino Design | Page 2
https://fassino.wordpress.com/page/2
Fassino Design News and Blog. News and ideas from Fassino Design. Newer posts →. Communicating Compassion: Fassino/Design Creates New Website, Messaging, and Visual Brand for Targacept. May 1, 2013. Targacept seeks to improve lives by working on therapeutics for unmet medical need. We worked with their communications team to communicate the company’s passion for patients and their dedication in seeking meaningful treatments for central nervous system disorders. March 15, 2013. By Design: Fassino/Design C...
babraham.co.uk
Babraham Bioscience Technologies Ltd - Bioincubator Companies
http://babraham.co.uk/companies/companies.html
The Babraham Research Campus is also home to The Babraham Institute. Babraham Research Campus - Cambridge - UK. Antitope is pioneering a new generation of immunogenicity testing and protein engineering technologies. Their mission is to apply these technologies to create improved non-immunogenic biologics. Biosceptre International (Biosceptre UK Limited). Cambridge Epigenetix (CEGX) is a biosciences company that aims to be the world leading provider of high quality, easy to use epigenetic tools. Their...
golgicareers.com
Golgi Careers
http://golgicareers.com/company/f-star
Developing novel bispecific antibodies directed at improving the treatment of serious diseases, with a focus on immuno-oncology and inflammatory diseases. Cambridge, United Kingdom. Http:/ www.f-star.com. 10 - 50 Employees. Why work for us. Scientist, Biology (F-star 037). Cambridge, United Kingdom. Research Associate, Pharmacology (F-star 036). Cambridge, United Kingdom.
babraham.com
Babraham Bioscience Technologies Ltd - Bioincubator Companies
http://www.babraham.com/companies/companies.html
The Babraham Research Campus is also home to The Babraham Institute. Babraham Research Campus - Cambridge - UK. Antitope is pioneering a new generation of immunogenicity testing and protein engineering technologies. Their mission is to apply these technologies to create improved non-immunogenic biologics. Biosceptre International (Biosceptre UK Limited). Cambridge Epigenetix (CEGX) is a biosciences company that aims to be the world leading provider of high quality, easy to use epigenetic tools. Their...
merck-ventures.com
Merck Ventures | F-Star
http://merck-ventures.com/portfolio/f-star
MS Ventures, Darmstadt. MS Ventures, Amsterdam. MS Ventures, Cambridge. Http:/ www.f-star.com. F-star Enters into Collaborative Discovery and Development Agreement with AbbVie for Bispecific Antibodies in Immuno-oncology. F-star today announced that it has entered into a collaboration and license agreement with AbbVie to research and develop bispecific antibodies in immuno-oncology. Merck Ventures BV, Amsterdam, The Netherlands.
srone.com
SR One - Applying insight. Creating value
http://www.srone.com/Default.aspx
Investment Focus and Approach. Modern healthcare venture capital investing requires a global scope. SR Ones geographic reach extends not only across North American and European markets, but also further afield in emerging economies. Venture creation and growth. SR One has assembled a team with a broad spectrum of relevant backgrounds whose collective insight benefits portfolio company management teams in the formation of companies, in the Board Room, and throughout transactions. Brenda D. Gavin, DVM.
SOCIAL ENGAGEMENT